Early cancer risk reduction after GLP-1RA use: Signal or bias?: Letter to the editor on “Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study”
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Korean Association for the Study of the Liver
2026-04-01
|
| Serie: | Clinical and Molecular Hepatology |
| Ämnen: | |
| Länkar: | http://e-cmh.org/upload/pdf/cmh-2025-0583.pdf |
| Taggar: |
Inga taggar, Lägg till första taggen!
|